Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:34 PM
Ignite Modification Date:
2025-12-24 @ 11:34 PM
NCT ID:
NCT03207256
Eligibility Criteria:
Inclusion Criteria:
* Subjects must be currently receiving treatment with ublituximab and/or TGR-1202 on a previously approved protocol.
* Subjects must have completed at least 6 cycles of therapy on their current protocol.
Exclusion Criteria:
* Subject progressed while receiving therapy with ublituximab and/or TGR-1202 while participating in their immediate previous trial.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT03207256
Study Brief:
Protocol Section:
NCT03207256